Rome, Italy

Nicola Fanto


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nicola Fanto: Innovator in Pharmaceutical Chemistry

Introduction

Nicola Fanto is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic applications. With a total of 2 patents, his work focuses on addressing inflammatory and autoimmune pathologies.

Latest Patents

Fanto's latest patents include "2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies." This patent specifically targets the prevention and treatment of inflammatory conditions, such as septic shock, where inflammatory cytokines play a crucial role. Another significant patent is for "Amides of alkanoyl L-carnitines of general formula (1)," which involves alkanoyl L-carnitine amides combined with amino acids, showcasing his innovative approach to pharmaceutical formulations.

Career Highlights

Nicola Fanto is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various inflammatory conditions.

Collaborations

Fanto collaborates with esteemed colleagues such as Giulio Taglialatela and Mose Santaniello. Their combined expertise enhances the innovative potential of their projects and contributes to the advancement of pharmaceutical science.

Conclusion

Nicola Fanto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to improving therapeutic treatments for inflammatory and autoimmune diseases. His work continues to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…